• 1. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 2. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 3. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 4. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 5. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Phenylpyridines

Pyridine, 5-bromo-2-fluoro-3-phenyl- (CAS No. 473596-03-1): A Comprehensive Overview

The compound Pyridine, 5-bromo-2-fluoro-3-phenyl- (CAS No. 473596-03-1) represents a significant advancement in the realm of chemical synthesis and pharmaceutical research. This heterocyclic aromatic compound has garnered considerable attention due to its unique structural and functional properties, making it a valuable building block in the development of novel therapeutic agents and agrochemicals.

Chemical Structure and Properties: The molecular structure of Pyridine, 5-bromo-2-fluoro-3-phenyl- consists of a pyridine ring substituted with a bromo group at the 5-position, a fluoro group at the 2-position, and a phenyl group at the 3-position. This arrangement imparts distinct electronic and steric characteristics to the molecule, influencing its reactivity and interactions with biological targets. The presence of both bromo and fluoro substituents enhances its utility in cross-coupling reactions, such as Suzuki-Miyaura and Buchwald-Hartwig couplings, which are pivotal in constructing complex organic molecules.

Applications in Pharmaceutical Research: In recent years, Pyridine, 5-bromo-2-fluoro-3-phenyl- has been extensively explored in the pharmaceutical industry for its potential as an intermediate in drug discovery. Its structural features make it an ideal candidate for designing molecules with specific biological activities. For instance, studies have demonstrated its role in synthesizing kinase inhibitors, which are crucial in treating cancers and inflammatory diseases. The fluoro substituent, in particular, is known to improve metabolic stability and bioavailability of drug candidates, making it a preferred choice for medicinal chemists.

Agrochemical Applications: Beyond pharmaceuticals, this compound has found applications in agrochemical research. The unique combination of substituents enhances its efficacy as a precursor for developing pesticides and herbicides. Recent research indicates that derivatives of Pyridine, 5-bromo-2-fluoro-3-phenyl- exhibit potent activity against resistant strains of pests, offering a promising solution to agricultural challenges.

Synthetic Methods: The synthesis of Pyridine, 5-bromo-2-fluoro-3-phenyl- involves multi-step organic transformations that highlight the compound's synthetic versatility. One common approach includes the bromination of a pyridine derivative followed by fluorination and subsequent phenylation. Advanced techniques such as transition-metal-catalyzed reactions have further optimized the synthesis, improving yield and purity. These methods align with contemporary trends toward greener chemistry, emphasizing sustainable practices in molecular construction.

Biological Activity and Mechanism of Action: The biological activity of compounds derived from Pyridine, 5-bromo-2-fluoro-3-phenyl- has been extensively studied. Research suggests that the bromo and fluoro groups modulate the interaction of these molecules with biological targets by influencing their electronic distribution and steric environment. For example, derivatives targeting protein kinases have shown promising results in preclinical trials due to their ability to inhibit aberrant signaling pathways involved in diseases such as cancer.

Future Prospects: As research continues to uncover new applications for Pyridine, 5-bromo-2-fluoro-3-phenyl-, its importance in chemical synthesis and drug development is expected to grow. Innovations in synthetic methodologies and an increased understanding of its biological interactions will likely lead to more efficient and targeted therapeutic interventions. The compound's versatility makes it a cornerstone in the quest for novel chemical entities with therapeutic potential.

Ethical Considerations: While the applications of Pyridine, 5-bromo-2-fluoro-3-phenyl- are promising, ethical considerations must be paramount in its use. Ensuring responsible research practices and equitable access to derived therapies are essential components of advancing chemical research for human health.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)